Progression from palindromic rheumatism to rheumatoid arthritis after COVID-19 vaccination.
Authors
Pankaj Bansal; Bhavin Sonani; Fawad Aslam;
Infections including COVID-19 infection are associated with immune overactivation and hyperinflammation, and cases of incident inflammatory arthritis after COVID-19 and other respiratory viral infections have been reported. Theoretical concerns of autoimmunity due to molecular mimicry exist with vaccines including vaccines for COVID-19, and rare cases of flares of underlying chronic inflammatory disorders such as systemic lupus erythematosus have been reported after COVID-19 vaccination. Here we present the case of a patient with a 7-year history of well-controlled palindromic rheumatism who developed rheumatoid arthritis 2 weeks after vaccination for COVID-19. This is the first such case to our knowledge, and further studies can elaborate on the risk of autoimmunity due to COVID-19 vaccines if one exists. Given the overall safety and efficacy of COVID-19 vaccines, the proven benefits of vaccinating vulnerable patients with autoimmune disorders outweigh this potential theoretical risk of autoimmune disease flare, and vaccinations in this at-risk population shall be strongly encouraged.
Pankaj Bansal
Mayo Clinic Health System
Bhavin Sonani
Department of Internal Medicine. HSHS St John’s Hospital
Fawad Aslam
Mayo Clinic Arizona
Mayo Clinic Health System
Bhavin Sonani
Department of Internal Medicine. HSHS St John’s Hospital
Fawad Aslam
Mayo Clinic Arizona